Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy M Goodwin

Showing results (141-150 of 258) with videos related to

Pageof 26
Sort By:
Brain and Behavior|September 15, 2021
The costs of bipolar disorder in the United KingdomJudit Simon, Anees A Abdul Pari, Jane Wolstenholme, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 27, 2013
Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult malesPhilippa L Rock, Catherine J Harmer, Sarah F B McTavish, et al.
Journal of Psychiatric Research|October 20, 2024
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionLindsey Marwood, Megan Croal, Sunil Mistry, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2018
Predicting treatment response to antidepressant medication using early changes in emotional processingMichael Browning, Jonathan Kingslake, Colin T Dourish, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2015
Lithium might be associated with better decision-making performance in euthymic bipolar patientsMarc Adida, Fabrice Jollant, Luke Clark, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Evidence-Based Mental Health|September 29, 2019
Value of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: a modelling studyJudit Simon, Catherine J Harmer, Jonathan Kingslake, et al.
Journal of Affective Disorders|May 19, 2015
Verbal learning impairment in euthymic bipolar disorder: BDI v BDIICorin Bourne, Amy Bilderbeck, Rebecca Drennan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 27, 2014
Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategiesValeria Frighi, Alireza Morovat, Matthew T Stephenson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 23, 2015
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trialLakshmi N Yatham, Eduard Vieta, Guy M Goodwin, et al.
Pageof 26

Showing results (141-150 of 258) with videos related to

Sort By:
Pageof 26
Brain and Behavior|September 15, 2021
The costs of bipolar disorder in the United KingdomJudit Simon, Anees A Abdul Pari, Jane Wolstenholme, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 27, 2013
Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult malesPhilippa L Rock, Catherine J Harmer, Sarah F B McTavish, et al.
Journal of Psychiatric Research|October 20, 2024
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depressionLindsey Marwood, Megan Croal, Sunil Mistry, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2018
Predicting treatment response to antidepressant medication using early changes in emotional processingMichael Browning, Jonathan Kingslake, Colin T Dourish, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 5, 2015
Lithium might be associated with better decision-making performance in euthymic bipolar patientsMarc Adida, Fabrice Jollant, Luke Clark, et al.
Journal of Psychopharmacology (Oxford, England)|May 22, 2019
Antidepressants, withdrawal, and addiction; where are we now?Sameer Jauhar, Joseph Hayes, Guy M Goodwin, et al.
Evidence-Based Mental Health|September 29, 2019
Value of monitoring negative emotional bias in primary care in England for personalised antidepressant treatment: a modelling studyJudit Simon, Catherine J Harmer, Jonathan Kingslake, et al.
Journal of Affective Disorders|May 19, 2015
Verbal learning impairment in euthymic bipolar disorder: BDI v BDIICorin Bourne, Amy Bilderbeck, Rebecca Drennan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 27, 2014
Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategiesValeria Frighi, Alireza Morovat, Matthew T Stephenson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 23, 2015
Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trialLakshmi N Yatham, Eduard Vieta, Guy M Goodwin, et al.
Pageof 26